DNA-constructs of blood clotting factors and P-Selectin

Details DNA-constructs of blood clotting factors and P-Selectin DNA-constructs of blood clotting factors and P-Selectin

1999-11-15

2002-07-16

Clark, Deborah J. R. (Department: 1633)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C424S192100, C435S320100, C435S455000, C530S381000, C530S384000, C536S023400, C536S023500

Reexamination Certificate

active

06419921

ABSTRACT:

Subject of this invention are DNA constructs encoding fusion proteins comprising amino acid sequences of blood coagulation factors and of P-Selectin.
P-Selectin is an integral transmembrane glycoprotein expressed in endothelial cells and platelets. P-Selectin is an inducible molecule implicated in cell-to-cell adhesion. The molecule is stored on resting cells in particular sub-cellular compartments: Weibel-Palade bodies in endothelial cells and a-granules in platelets. The intracellular domain of P-Selectin (psel) was shown to be responsible for the targeting of the molecule in different compartments: storage granules, lysosomes, dense-core granules and synaptic-like-microvesicles [2, 4, 5]. Two chimeric molecules were generated using this domain: Tissue-Factor-psel and Horse-Radish Peroxidase (HRP)-psel. In both cases, using secretion-regulated cell lines (AtT20 and PC12), the chimeric molecules were directed into secretory granules and lysosomes [2, 6]. The intracellular tail possesses two distinct stretches of amino acids implicated in the targeting. The 10 amino acids close to the plasma membrane direct P-Selectin and HRP-psel in lysosomes, whereas the 3′extremity is required for the targeting in synaptic-like microvesicles, i.e., secretory vesicles [1, 6]. The targeting potential of the cytoplasmic tail was also shown to be increased in the presence of the transmembrane domain. When both domains were present, a chimeric E-selectin-P-selectin was more efficiently directed into granules [3].
The addition of the P-Selectin tail seems to represent an interesting tool for targeting genetic factors of therapeutic interest into intracellular storage compartments where they can be useful for somatic gene therapy. The present invention shows that DNA constructs of blood clotting factors like Factor IX and of P-Selectin create new possibilities for the treatment of patients suffering from a defiency of blood coagulation factors. It is directed to chimeric molecules comprising inter alia FIX-DNA constructs fused with the cytoplasmic domain of P-Selectin.
It has been found that a DNA construct encoding a fusion protein comprising an amino acid sequence of a blood clotting factor and an amino acid sequence of the cytoplasmic domain of human P-Selectin retains the full blood coagulation activity and has valuable properties which are useful for the somatic gene therapy of patients suffering from a defiency of a blood coagulation factor like Factor IX.


REFERENCES:
patent: 5198424 (1993-03-01), McEver
patent: 5877289 (1999-03-01), Thorpe et al.
patent: 98122883.6 (1998-12-01), None
patent: WO 97/11684 (1997-04-01), None
patent: WO 98/42850 (1998-10-01), None
Ledley et al. Pharmaceutical Research. 13: 1595-1614, Nov. 1996.*
Miller et al. FASEB J. 9: 190-199, Feb. 1995.*
Verma et al. Nature. 389: 239-242, Sep. 1997.*
Blagoveshchenskaya, Anastasia D. et al., “Lysosomal Targeting of P-Selectin Is Mediated By A Novel Sequence Within Its Cytoplasmic Tail”, The Journal of Biological Chemistry, vol. 273, No. 5, Jan. 30, 1998, pp. 2729-2737.
Disdier, Magali et al., “Cytoplasmic Domain of P-Selectin (CD62) Contains the Signal for Sorting Into The Regulated Secretory Pathway”, Molecular Biology of the Cell, vol. 3, Mar. 1992, pp. 309-321.
Fleming, Judith C. et al., “The Transmembrane Domain Enhances Granular Targeting of P-Selectin”, European Journal of Cell Biology 75, Apr. 1998, pp. 331-343.
Green, Samuel A., “The Cytoplasmic Domain of P-Selectin Contians a Sorting Determinant That Mediates Rapid Degradation in Lysosomes,” The Journal of Cell Biology, Vo1, 124, No. 4, Feb. 1994, pp. 435-448.
Koedam, Joost A. et al., “P-Selectin, A Granule Membrane Protein of Platelets and Endothelial Cells, Follows The Regulated Secretory Pathway in AtT-20 Cells,” The Journal of Cell Biology, vol. 116, No. 3, Feb. 1992, pp. 617-625.
Norcott, John P. et al., “Target of P-Selectin to Two Regulated Secretory Organelles in PC12 Cells,” The Journal of Cell Biology, vol. 134, No. 5, Sep. 1996, pp. 1229-1240.
Kozak, Marilyn, “Point Mutations Define a Sequence Flanking the AUG Initiator Codon That Modulates Translation by Eukaryotic Ribosomes,” Univ. of Pittsburgh, Dept. of Biological Sciences, vol. 44, Jan. 31, 1986, pp. 283-292.
Kurachi, Sumiko et al., “Role of Intron I in Expression of the Human Factor IX Gene,” The Journal of Biological Chemistry, vol. 270, No. 10, Mar. 10, 1995, pp. 5276-5281.
Kurachi, Sumiko et al., “Role of Intron I in Expression of the Human Factor IX Gene”, The Journalof Biological Chemistry, vol. 270, No. 10, pp. 5276-5281 (Mar. 10, 1995).
Green, Samuel A. et al., “The Cytoplasmic Domain of P-Selectin Contains a Sorting Determinant That Mediates Rapid Degradation in Lysosomes”, The Journal of Cell Biology, vol. 124, No. 4, pp. 435-448 (Jan. 1, 1994).
Disdier, Magali et al., “Cytoplasmic Domain of P-Selectin (CD62) Contains the Signal for Sorting into the Regulated Secretory Pathway”, Molecular Biology of the Cell, vol. 3, pp. 309-321(Mar. 1, 1992).
Norcott, John P. et al., “Targeting of P-Selectin to Two Regulated Secretory Organelles in PC12 Cells”, The Journal of Cell Biology, vol. 134, No. 5, pp. 1229-1240(Sep. 1996).
Plantier, Jean-Luc et al., “P-Selectin Tail Induces The Storage of Factor IX in Cho Cells”, Blood, vol. 92, No. 10, pp. 380B (Nov. 15 1998), Abstract.
European Search Report (Apr. 5, 2000).

Affiliated with

Also associated with

Rating

DNA-constructs of blood clotting factors and P-Selectin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with DNA-constructs of blood clotting factors and P-Selectin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA-constructs of blood clotting factors and P-Selectin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2823254